Nanobiotix receives €14 million through the second tranche disbursement of financing from the European Investment Bank

    NEXT STORY
    Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
    PREV STORY
    Gradalis Announces Medical Leadership Team Promotion
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index

    CAMBRIDGE, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology ...

    author_avatar
    NASDAQ Market News

    Moffitt Cancer Center Takes Whole-Patient Treatment to Heart

    author_avatar
    NASDAQ Market News

    Sorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018

    SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced ...

    author_avatar
    NASDAQ Market News